Relay Therapeutics Inc (RLAY)
4.75
+0.11
(+2.37%)
USD |
NASDAQ |
Nov 22, 16:00
4.74
-0.01
(-0.21%)
After-Hours: 20:00
Relay Therapeutics Market Cap: 795.07M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 795.07M |
| November 21, 2024 | 776.66M |
| November 20, 2024 | 780.00M |
| November 19, 2024 | 803.44M |
| November 18, 2024 | 818.50M |
| November 15, 2024 | 854.49M |
| November 14, 2024 | 937.34M |
| November 13, 2024 | 972.50M |
| November 12, 2024 | 994.26M |
| November 11, 2024 | 1.031B |
| November 08, 2024 | 1.038B |
| November 07, 2024 | 1.028B |
| November 06, 2024 | 1.046B |
| November 05, 2024 | 995.93M |
| November 04, 2024 | 979.19M |
| November 01, 2024 | 977.52M |
| October 31, 2024 | 940.41M |
| October 30, 2024 | 952.92M |
| October 29, 2024 | 984.63M |
| October 28, 2024 | 1.006B |
| October 25, 2024 | 1.005B |
| October 24, 2024 | 1.033B |
| October 23, 2024 | 1.051B |
| October 22, 2024 | 1.111B |
| October 21, 2024 | 1.073B |
| Date | Value |
|---|---|
| October 18, 2024 | 1.123B |
| October 17, 2024 | 1.108B |
| October 16, 2024 | 1.135B |
| October 15, 2024 | 1.125B |
| October 14, 2024 | 1.126B |
| October 11, 2024 | 1.135B |
| October 10, 2024 | 1.098B |
| October 09, 2024 | 1.070B |
| October 08, 2024 | 1.043B |
| October 07, 2024 | 1.058B |
| October 04, 2024 | 1.090B |
| October 03, 2024 | 1.083B |
| October 02, 2024 | 1.083B |
| October 01, 2024 | 1.093B |
| September 30, 2024 | 1.182B |
| September 27, 2024 | 1.244B |
| September 26, 2024 | 1.234B |
| September 25, 2024 | 1.177B |
| September 24, 2024 | 1.216B |
| September 23, 2024 | 1.239B |
| September 20, 2024 | 1.251B |
| September 19, 2024 | 1.311B |
| September 18, 2024 | 1.264B |
| September 17, 2024 | 1.267B |
| September 16, 2024 | 1.352B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
740.20M
Minimum
Oct 25 2023
5.532B
Maximum
Jan 22 2021
2.286B
Average
2.248B
Median
Market Cap Benchmarks
| Pfizer Inc | 145.36B |
| Summit Therapeutics Inc | 14.01B |
| Biomarin Pharmaceutical Inc | 12.25B |
| Lexicon Pharmaceuticals Inc | 312.11M |
| Arbutus Biopharma Corp | 665.12M |
Market Cap Related Metrics
| PS Ratio | 17.77 |
| Price to Book Value | 0.9478 |
| Price | 4.75 |
| Earnings Yield | -54.95% |